Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches

Abstract The reported incidence and prevalence of atrial fibrillation (AF) has been inconsistent across published studies. Using the National Health Insurance Service database of Korea, the prevalence and incidence of AF, and oral anticoagulation (OAC) use of AF patients were explored according to t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pil-Sung Yang, Soorack Ryu, Daehoon Kim, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Jinseub Hwang, Boyoung Joung, Gregory Y. H. Lip
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3d38473217134c36b90c9ed7eea526da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3d38473217134c36b90c9ed7eea526da
record_format dspace
spelling oai:doaj.org-article:3d38473217134c36b90c9ed7eea526da2021-12-02T12:32:11ZVariations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches10.1038/s41598-018-25111-62045-2322https://doaj.org/article/3d38473217134c36b90c9ed7eea526da2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25111-6https://doaj.org/toc/2045-2322Abstract The reported incidence and prevalence of atrial fibrillation (AF) has been inconsistent across published studies. Using the National Health Insurance Service database of Korea, the prevalence and incidence of AF, and oral anticoagulation (OAC) use of AF patients were explored according to three different approaches; ‘formal approach’, considering individual AF diagnosis and mortality; ‘limited diagnosis approach’, using upper 5 main diagnosis; and ‘medical use approach’, using the number of medical use AF population by year without considering individual AF history and mortality. The AF prevalence progressively increased by 2.46-fold from 0.50% in 2004 to 1.54% in 2015 when using a ‘formal approach’ (p for trend <0.001). The overall prevalence was 1.09% and 0.97% when using a ‘formal approach’ and ‘limited diagnosis approaches’, respectively. Overall prevalence decreased to 0.52% with a ‘medical use approach’. The trend of annual AF incidence was stable when using a ‘formal approach’, but increased by 15% when using a ‘medical use approach’. OAC rate in 2015 was 2.1 times higher when using a ‘medical use approach’ compared to using a ‘formal approach’ (40.3% vs. 19.1%, p < 0.001). Given the wide variability in prevalence and incidence figures with different analysis approaches, careful attention to the analysis methodology is needed.Pil-Sung YangSoorack RyuDaehoon KimEunsun JangHee Tae YuTae-Hoon KimJinseub HwangBoyoung JoungGregory Y. H. LipNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-5 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pil-Sung Yang
Soorack Ryu
Daehoon Kim
Eunsun Jang
Hee Tae Yu
Tae-Hoon Kim
Jinseub Hwang
Boyoung Joung
Gregory Y. H. Lip
Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
description Abstract The reported incidence and prevalence of atrial fibrillation (AF) has been inconsistent across published studies. Using the National Health Insurance Service database of Korea, the prevalence and incidence of AF, and oral anticoagulation (OAC) use of AF patients were explored according to three different approaches; ‘formal approach’, considering individual AF diagnosis and mortality; ‘limited diagnosis approach’, using upper 5 main diagnosis; and ‘medical use approach’, using the number of medical use AF population by year without considering individual AF history and mortality. The AF prevalence progressively increased by 2.46-fold from 0.50% in 2004 to 1.54% in 2015 when using a ‘formal approach’ (p for trend <0.001). The overall prevalence was 1.09% and 0.97% when using a ‘formal approach’ and ‘limited diagnosis approaches’, respectively. Overall prevalence decreased to 0.52% with a ‘medical use approach’. The trend of annual AF incidence was stable when using a ‘formal approach’, but increased by 15% when using a ‘medical use approach’. OAC rate in 2015 was 2.1 times higher when using a ‘medical use approach’ compared to using a ‘formal approach’ (40.3% vs. 19.1%, p < 0.001). Given the wide variability in prevalence and incidence figures with different analysis approaches, careful attention to the analysis methodology is needed.
format article
author Pil-Sung Yang
Soorack Ryu
Daehoon Kim
Eunsun Jang
Hee Tae Yu
Tae-Hoon Kim
Jinseub Hwang
Boyoung Joung
Gregory Y. H. Lip
author_facet Pil-Sung Yang
Soorack Ryu
Daehoon Kim
Eunsun Jang
Hee Tae Yu
Tae-Hoon Kim
Jinseub Hwang
Boyoung Joung
Gregory Y. H. Lip
author_sort Pil-Sung Yang
title Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
title_short Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
title_full Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
title_fullStr Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
title_full_unstemmed Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
title_sort variations of prevalence and incidence of atrial fibrillation and oral anticoagulation rate according to different analysis approaches
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/3d38473217134c36b90c9ed7eea526da
work_keys_str_mv AT pilsungyang variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT soorackryu variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT daehoonkim variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT eunsunjang variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT heetaeyu variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT taehoonkim variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT jinseubhwang variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT boyoungjoung variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
AT gregoryyhlip variationsofprevalenceandincidenceofatrialfibrillationandoralanticoagulationrateaccordingtodifferentanalysisapproaches
_version_ 1718394149619630080